Masitinib for the treatment of locally advanced or metastatic pancreatic cancer [ID566]

Pancreatic cancer (locally advanced, metastatic) - masitinib: response to consultee and commentator comments on the draft scope

Pancreatic cancer (locally advanced, metastatic) - masitinib: final scope

Pancreatic cancer (locally advanced, metastatic) - masitinib: final matrix

Pancreatic cancer (locally advanced, metastatic) - masitinib: equality impact assessment - scoping